Ratos's investment in Perlos Healthcare proceeds
Ratos's acquisition of 78% of Perlos Healthcare has today proceeded to the next stage, as Ratos have signed a definite sale and purchase agreement with all parties involved. The closing of the deal is expected to take place by the end of this year after the approval of the competition authorities has been received and other closing conditions of the transaction have been fulfilled.
The cash and debt free purchase price of Perlos's healthcare business by the new company is approximately EUR 67m. The purchase price will be paid in cash.
Ratos will make a maximum of EUR 30.4m equity investment in the newly formed holding company. Perlos Healthcare business unit's acting management will acquire approximately 2% and Perlos OY will hold on to an ownership stake of 20%.
The net sales of Perlos Healthcare business unit amounted to EUR 52.6m in 2005.
For further information, please contact:
Arne Karlsson, CEO Ratos, +46 8 700 17 00
Anna-Karin Celsing, Head of Corporate Communications Ratos, +46 70 399 62 39
Financial calendar from Ratos:
| Interim report January-June 2006 | 24 August 2006 |
| Interim report January-September 2006 | 10 November 2006 |
Ratos is a listed private equity company. The business concept is to maximise shareholder value over time by investing in, developing and divesting primarily unlisted companies. Ratos thus offers stock market players a unique investment opportunity. The equity of Ratos's investments is approximately SEK 11 billion. Ratos's holdings include Alimak Hek, Arcus, Anticimex, Atle Industri, Bisnode, Bluegarden, BTJ Group, Camfil, DIAB, Gadelius, GS-Hydro, Haendig, Haglöfs, HL Display, Hägglunds Drives, Industri Kapital, Inwido, Jøtul, Lindab, Overseas Telecom and Superfos.